Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Biodelivery Sci Intl (BDSI)

Biodelivery Sci Intl (BDSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 577,050
  • Shares Outstanding, K 103,229
  • Annual Sales, $ 166,700 K
  • Annual Income, $ 84,860 K
  • 60-Month Beta 0.56
  • Price/Sales 3.46
  • Price/Cash Flow 15.44
  • Price/Book 2.94
Trade BDSI with:
  • Price/Earnings ttm 21.52
  • Earnings Per Share ttm 0.26
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date 05/05/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/22
See More
  • Average Estimate 0.08
  • Number of Estimates 1
  • High Estimate 0.08
  • Low Estimate 0.08
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.53 +1.08%
on 03/01/22
5.62 -0.53%
on 02/28/22
+0.04 (+0.72%)
since 02/22/22
3-Month
2.95 +89.49%
on 01/19/22
5.62 -0.53%
on 02/28/22
+2.36 (+73.07%)
since 12/22/21
52-Week
2.50 +123.60%
on 12/13/21
5.62 -0.53%
on 02/28/22
+1.67 (+42.60%)
since 03/22/21

Most Recent Stories

More News
Collegium Completes the Acquisition of BDSI

STOUGHTON, Mass., March 22, 2022 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) (“Collegium”) today announced that it has completed...

COLL : 34.87 (+0.29%)
BDSI : 5.59 (-0.09%)
Merck (MRK) Keytruda Gets Another FDA Nod in Endometrial Cancer

Merck's (MRK) Keytruda gets approval for advanced endometrial carcinoma therapy in certain patients who are not suited for curative surgery or radiation.

AZN : 68.56 (+0.29%)
MRK : 125.82 (+0.47%)
VRTX : 394.53 (+0.27%)
BDSI : 5.59 (-0.09%)
Has BioDelivery Sciences International (BDSI) Outpaced Other Medical Stocks This Year?

Here is how BioDelivery Sciences International (BDSI) and Vertex Pharmaceuticals (VRTX) have performed compared to their sector so far this year.

BDSI : 5.59 (-0.09%)
VRTX : 394.53 (+0.27%)
Catalyst (CPRX) Q4 Earnings Lag Estimates, Revenues Rise Y/Y

Catalyst's (CPRX) fourth-quarter 2021 earnings miss estimates while revenues slightly beat the mark.

VRTX : 394.53 (+0.27%)
BDSI : 5.59 (-0.09%)
CPRX : 15.12 (-1.43%)
KLDO : 0.0001 (unch)
Incyte (INCY) Label Expansion for Ruxolitinib Cream Delayed

Incyte' s (INCY) sNDA seeking label expansion of ruxolitinib cream gets extended by three months by the FDA for reviewing additional information.

NVS : 94.36 (+1.93%)
VRTX : 394.53 (+0.27%)
INCY : 52.31 (-0.97%)
BDSI : 5.59 (-0.09%)
Moderna (MRNA) Early-Stage HIV Vaccine Study Begins, Stock Up

Moderna (MRNA) starts dosing in an mRNA-based HIV vaccine study.

PFE : 25.98 (+2.32%)
VRTX : 394.53 (+0.27%)
MRNA : 101.39 (-0.60%)
BDSI : 5.59 (-0.09%)
Novartis (NVS) Announces Data on Zolgensma, Acquires Coalesce

Novartis (NVS) reports positive data on SMA treatment from a phase III study. It also acquires Coalesce Product Development Limited to strengthen its respiratory and complex generics business.

NVS : 94.36 (+1.93%)
VRTX : 394.53 (+0.27%)
BDSI : 5.59 (-0.09%)
VYGR : 7.49 (-0.79%)
Why is Viatris (VTRS) Stock Down 25% in the Year So Far?

Viatris (VTRS) stock drops 25% in the year so far as investors do not seem to be impressed by the impending sale of its biosimilar business.

PFE : 25.98 (+2.32%)
VRTX : 394.53 (+0.27%)
BDSI : 5.59 (-0.09%)
VTRS : 11.25 (+1.17%)
Intellia (NTLA) Depreciates 27% Over a Month: Here's Why

Intellia's (NTLA) shares decline following the decision of the USPTO, invalidating the patents licensed by Intellia to develop CRISPR-based gene therapies.

REGN : 895.82 (+0.20%)
BDSI : 5.59 (-0.09%)
NTLA : 21.57 (+1.17%)
CRSP : 55.06 (-1.96%)
Catalyst (CPRX) Skyrockets 110% Over a Year: Here's Why

Catalyst's (CPRX) stock price has more than doubled in the past year, driven by its sole marketed drug, Firdapse, approved for the treatment of Lambert-Eaton Myasthenic Syndrome in adults.

VRTX : 394.53 (+0.27%)
BDSI : 5.59 (-0.09%)
CPRX : 15.12 (-1.43%)
COLL : 34.87 (+0.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioDelivery Sciences International is a development-stage biotechnology company that is developing and seeking to commercialize a drug delivery technology designed for a potentially broad base of pharmaceuticals, vaccines and over-the-counter drugs. In general, a drug delivery technology refers to any...

See More

Key Turning Points

3rd Resistance Point 5.61
2nd Resistance Point 5.60
1st Resistance Point 5.60
Last Price 5.59
1st Support Level 5.59
2nd Support Level 5.58
3rd Support Level 5.58

See More

52-Week High 5.62
Last Price 5.59
Fibonacci 61.8% 4.43
Fibonacci 50% 4.06
Fibonacci 38.2% 3.69
52-Week Low 2.50

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar